Journal of general internal medicine
Ethical Considerations in the Use of Weight Loss Medications.
Riya Savla, Anne Marie Van Hoven, Bryan Pilkington
Published: 202510.1007/s11606-025-10026-6
Abstract
The emergence of GLP-1 receptor agonists, such as semaglutide and tirzepatide, has transformed the landscape of weight management and diabetes treatment. Initially developed for type 2 diabetes mellitus, these medications have gained widespread popul…
Preview only. Read the full abstract at the source